Committed to sharing our science

Committed to sharing our science

338 results available

Clinical Application of Biomarkers in Obstructive HCM: Insights from SEQUOIA-HCM

Oral Presentation, ESC 2024

Coats CJ, et al.

London, England

September 1, 2024
Effect of Aficamten on Cardiac Structure and Function in Patients with Obstructive Hypertrophic Cardiomyopathy: The SEQUOIA-HCM CMR Trial

Oral Presentation, ESC 2024

Masri A, et al.

London, England

September 1, 2024
Effect of Aficamten on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM

Oral Presentation, ESC 2024

Spertus J, et al.

London, England

September 1, 2024
Cardiac Myosin Inhibitor, CK-586, Minimally Reduces Systolic Function and Ameliorates Obstruction in Feline Hypertrophic Cardiomyopathy

Scientific Reports

Rivas VN, et al.

May 27, 2024
In Vitro and In Vivo Pharmacokinetic Preclinical Characterization of Aficamten, a Small Molecule Cardiac Myosin Inhibitor

Xenobiotica

Sukhun, R et al

August 5, 2024